Acurx Pharmaceuticals Inc... (ACXP)
undefined
undefined%
At close: undefined
0.81
-4.15%
Pre-market Dec 16, 2024, 05:59 AM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -14.58M -12.09M -12.75M -4.60M -5.93M
Depreciation & Amortization - - - - -
Stock-Based Compensation 3.77M 3.30M 6.74M 1.27M 900.43K
Other Working Capital 30.02K 30.35K -387.84M -801.17K 1.05M
Other Non-Cash Items 980.75K 3.30M 850.26K 781.70K 900.43K
Deferred Income Tax - - - - -
Change in Working Capital 30.02K 1.25M 141.28K -801.17K 1.05M
Operating Cash Flow -9.80M -7.54M -5.01M -3.35M -3.99M
Capital Expenditures 5.00 - - - -
Acquisitions - - - - -
Purchase of Investments - - - - -
Sales Maturities Of Investments - - - - -
Other Investing Acitivies - - - - -
Investing Cash Flow - - - - -
Debt Repayment - - - 66.50K -
Common Stock Repurchased - - - - -
Dividend Paid - - - - -
Other Financial Acitivies 2.22M 13.00 - - -
Financial Cash Flow 8.16M 3.70M 14.80M 4.04M 4.46M
Net Cash Flow -1.64M -3.85M 9.78M 692.09K 470.17K
Free Cash Flow -9.80M -7.54M -5.01M -3.35M -3.99M